Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Operational Update June 4, 2025 Next Post Mali Court Adjourns Barrick’s Gold Complex Hearing Over Deepening Taxes, Control Dispute June 4, 2025 Related Posts Grande Portage Applies for Road Easement from State of Alaska August 23, 2025 Gold Price Rises as Powell Boosts Rate Cut Expectations in Jackson Hole Speech August 23, 2025 OPINION — Goldenomics 104: Trump’s Tariffs and Gold August 23, 2025
